...
首页> 外文期刊>Journal of nuclear medicine technology >Evaluation of tumor-induced osteomalacia with 111in-pentetreotide scintigraphy
【24h】

Evaluation of tumor-induced osteomalacia with 111in-pentetreotide scintigraphy

机译:111in-戊戊肽闪烁显像技术评价肿瘤性骨软化症

获取原文
获取原文并翻译 | 示例
           

摘要

In cases of nonhereditary osteomalacia associated with hypophosphatemia and inadequate response to vitamin D supplementation, one should consider the possibility of tumor-induced osteomalacia, a paraneoplastic syndrome caused by small mesenchymal tumors often found in obscure locations. We present a case of tumor-induced osteomalacia in which 111In-pentetreotide scintigraphy aided in accurate localization of the culprit brachial plexus tumor and cure after resection.
机译:如果发生非遗传性骨软化症并伴有低磷酸盐血症,且对维生素D的补充反应不足,则应考虑肿瘤引起的骨软化症的可能性,这种骨软化症通常是由隐匿于小部位的间充质肿瘤引起的。我们介绍了一例由肿瘤引起的骨软化症,其中111 In-pentetreotide闪烁显像术有助于准确定位罪犯臂丛神经肿瘤并在切除后治愈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号